News articles about R1 RCM (NYSE:RCM) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. R1 RCM earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave headlines about the company an impact score of 47.3957549768631 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Separately, Zacks Investment Research upgraded R1 RCM from a “hold” rating to a “buy” rating and set a $4.00 price target on the stock in a research note on Thursday, July 6th.
R1 RCM (RCM) opened at 3.17 on Friday. The stock’s 50 day moving average price is $4.48 and its 200 day moving average price is $3.84. R1 RCM has a 52 week low of $1.61 and a 52 week high of $4.37.
R1 RCM (NYSE:RCM) last posted its earnings results on Wednesday, August 2nd. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by $0.07. R1 RCM had a negative return on equity of 51.77% and a negative net margin of 6.74%. The firm had revenue of $99.40 million for the quarter, compared to analyst estimates of $91.95 million. On average, equities analysts forecast that R1 RCM will post ($0.04) earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This report was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this report on another publication, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The legal version of this report can be read at https://stocknewstimes.com/2017/08/19/r1-rcm-nysercm-given-daily-news-impact-rating-of-0-12-updated.html.
R1 RCM Company Profile
R1 RCM Inc, formerly Accretive Health, Inc, is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers.
Receive News & Ratings for R1 RCM Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM Inc and related companies with MarketBeat.com's FREE daily email newsletter.
